NEW YORK, Dec. 16 (Xinhua) -- Drugs are more a tool to optimize performance at Wall Street, especially for entry-level bankers at the analyst and associate level, who work long, tedious hours and fiercely compete for higher-level jobs with big pay days, with prescriptions for stimulants such as Adderall and other ADHD (Attention-deficit/hyperactivity disorder) drugs becoming commonplace, reported The Wall Street Journal (WSJ) on Monday.
"The feeling that the jobs can't be done without stimulants comes as Wall Street is under fire for pushing junior bankers to take on dangerous workloads," noted the report.
Interviews with more than 50 current and former investment bankers at over a dozen banks about how they cope with long hours and high-pressure jobs made clear that the use of stimulants is openly discussed and visible in workplaces, said the report.
The immense financial rewards of working on Wall Street, with starting banker salaries reaching 200,000 U.S. dollars, can push people to use drugs to improve their performance, it added.
